Yungjin Pharm Co Ltd (003520) — Cash Flow Reinvestment Rate
Yungjin Pharm Co Ltd (003520) has a Cash Flow Reinvestment Rate of 0.61x as of September 2025, reinvesting ₩4.28 Billion (capex ₩2.16 Billion plus investments ₩-2.12 Billion) from operating cash flow of ₩7.00 Billion. See free cash flow generation of Yungjin Pharm Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yungjin Pharm Co Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Yungjin Pharm Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see 003520 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Yungjin Pharm Co Ltd. See 003520 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.13x | ₩24.61 Billion | ₩21.74 Billion | ₩21.61 Billion | ▼ -19.9% |
| 2021 | 1.41x | ₩11.82 Billion | ₩8.37 Billion | ₩11.32 Billion | ▲ +71.3% |
| 2020 | 0.82x | ₩11.96 Billion | ₩14.50 Billion | ₩6.30 Billion | ▼ -63.0% |
| 2019 | 2.23x | ₩20.69 Billion | ₩9.28 Billion | ₩10.36 Billion | ▼ -61.3% |
| 2018 | 5.76x | ₩7.34 Billion | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.4% |
| 2017 | 5.26x | ₩16.59 Billion | ₩3.15 Billion | ₩10.59 Billion | ▲ +240.9% |
| 2016 | 1.54x | ₩4.81 Billion | ₩3.11 Billion | ₩4.69 Billion | ▼ -10.4% |
| 2015 | 1.72x | ₩15.16 Billion | ₩8.80 Billion | ₩13.75 Billion | ▼ -6.1% |
| 2014 | 1.84x | ₩11.41 Billion | ₩6.22 Billion | ₩11.30 Billion | ▲ +38.1% |
| 2013 | 1.33x | ₩7.91 Billion | ₩5.95 Billion | ₩6.63 Billion | — |